Skip to main content
Log in

Early vertebroplasty within 3 weeks of fracture for acute painful vertebral osteoporotic fractures: subgroup analysis of the VAPOUR trial and review of the literature

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Background

VAPOUR found vertebroplasty (V) more effective than placebo (P) in patients with severe pain and fracture duration less than 6 weeks. Exploratory analysis suggested that benefits were concentrated in the subgroup of patients with fractures ≤ 3-week duration. This difference may account for the three negative blinded trials that included few patients within this fracture time frame.

Purpose

To assess the safety and efficacy of early vertebroplasty for acute painful vertebral osteoporotic fractures within 3 weeks of fracture onset in the VAPOUR study.

Methods

Spearman’s rank log coefficients were calculated to reassess the relationship of pain reduction from vertebroplasty and fracture duration in the VAPOUR trial. We more fully report baseline and outcome data in patients with fractures ≤ 3-week duration.

Results

There were 46V and 47P patients with fractures ≤ 3-week duration. Baseline characteristics were similar. In total, 86 patients (41V, 45P) completed the 14-day questionnaire. The proportion of patients with reduction in pain from severe (NRS ≥ 7/10 was an inclusion requirement) to mild (NRS < 4) at 14 days was 21 (51%) V-group and 9 (20%) in the P-group (between-group difference 31 percentage points, 95% CI 12–50; p = 0.002). Early vertebroplasty provided greater reductions in mean NRS pain and Roland–Morris Disability.

Conclusion

Analysis of this patient subgroup from the VAPOUR trial, in the context of other randomised trial evidence, suggests clinically significant benefits from early vertebroplasty if performed within 3 weeks of fracture.

Graphic abstract

These slides can be retrieved from Electronic Supplementary Material.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Clark W, Bird P, Gonski P et al (2016) Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double blind, placebo-controlled trial. Lancet 388:1408–1416

    Article  Google Scholar 

  2. Kallmes DF, Comstock BA, Heagerty PJ et al (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361:569–579

    Article  CAS  Google Scholar 

  3. Buchbinder R, Osborne RH, Ebeling PR et al (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 361:557–568. https://doi.org/10.1056/NEJMoa0900429pmid:19657121

    Article  CAS  PubMed  Google Scholar 

  4. Firanescu CE, de Vries J, Lodder P et al (2018) Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ. https://doi.org/10.1136/bmj.k1551

    Article  PubMed  PubMed Central  Google Scholar 

  5. ClinicalTrials.gov (2000) Identifier: NCT01482793. A controlled trial of vertebroplasty for acute painful osteoporotic fractures. National Library of Medicine (US), Bethesda. About 4 screens. https://clinicaltrials.gov/ct2/show/study/NCT01482793?cond=vertebroplasty&draw=4&rank=21. (Cited 31 Aug 2019)

  6. Roland M, Fairbank J (2000) The Roland–Morris disability questionnaire and the Oswestry disability questionnaire. Spine 25:3115–3124

    Article  CAS  Google Scholar 

  7. Genant HK, Wu CY, van Kujik C, Nevitt MC (1993) Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 8:1137–1148

    Article  CAS  Google Scholar 

  8. Hasserius R, Karlsson MK, Jonsson B, Redlund-Johnell I, Johnell O (2005) Long term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly—a 12 and 22 year follow up of 257 patients. Calcif Tissue Int 76(4):235–242

    Article  CAS  Google Scholar 

  9. Ong T, Kantachuvesiri P, Sahota O, Gladman JRF (2018) Characteristics and outcomes of hospitalised patients with vertebral fragility fractures: a systematic review. Age Ageing 47:17–25. https://doi.org/10.1093/ageing/afx079

    Article  PubMed  Google Scholar 

  10. Ong T, Sahota O, Gladman JRF (2019) The Nottingham Spinal Health (NoSH) Study: a cohort of patients hospitalised with vertebral fragility fractures. Osteoporos Int. https://doi.org/10.1007/s00198-019-05198x

    Article  PubMed  PubMed Central  Google Scholar 

  11. Diamond TH, Champion B, Clark WA (2003) Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med 114:257–265

    Article  Google Scholar 

  12. Diamond TH, Clark WA, Kumar SV (2007) Histomorphometric analysis of fracture healing cascade in acute osteoporotic vertebral body fractures. Bone 40(3):775–780

    Article  Google Scholar 

  13. Farrar JT, Portenoy RK, Berlin JA et al (2000) Defining the clinically important difference in pain outcome measures. Pain 88:287–294

    Article  CAS  Google Scholar 

  14. Buchbinder R, Johnston RV, Rischin KJ et al (2018) Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Datab Syst Rev 11:CD006349. https://doi.org/10.1002/14651858.CD006349.pub4

    Article  Google Scholar 

  15. Hansen EJ, Simony A, Rousing R, Carreon LY, Tropp H, Andersen MO (2016) Double blind placebo-controlled trial of percutaneous vertebroplasty (VOPE). Glob Spine J. https://doi.org/10.1055/s-0036-1582763

    Article  Google Scholar 

  16. Yang EZ, Xu JG, Huang GZ et al (2016) Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine 41:653–656

    Article  Google Scholar 

  17. Rousing R, Hansen KL, Andersen MO, Jespersen SM, Thomsen K, Lauritsen JM (2010) Twelve-months follow-up in forty-nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine 35:478–482

    Article  Google Scholar 

  18. Katz NP, Paillard FC, Ekman E (2015) Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. J Orthop Surg Res 10:24

    Article  Google Scholar 

  19. Lambert RGW, Golmohammadi K, Majumdar SR et al (2007) Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database Syst Rev 1:CD006349

    Google Scholar 

  20. Clark W, Bird P, Diamond T et al (2019) The Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patients. BMJ Evid Based Med. https://doi.org/10.1136/bmjebm-2019-111171

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ebeling PR, Akesson K, Bauer DC et al (2019) The efficacy and safety of vertebral augmentation: a second ASBMR Task Force Report. J Bone Miner Res 34(1):3–21. https://doi.org/10.1002/jbmr.3653

    Article  PubMed  Google Scholar 

  22. Diamond T, Clark W, Bird P, Gonski P (2019) Percutaneous vertebroplasty for acute painful osteoporotic vertebral fractures—benefits shown in VAPOUR trial masked when pooled with other clinical trials. Diamond 34:1182–1184. https://doi.org/10.1002/jbmr.3725

    Article  Google Scholar 

  23. Chandra RV, Maingard J, Asadi H et al (2018) Vertebroplasty and kyphoplasty for osteoporotic vertebral fractures: what are the latest data? Am J Neuroradiol 39:798–806. https://doi.org/10.3174/ajnr.A5458

    Article  CAS  PubMed  Google Scholar 

  24. Lou S, Shi X, Zhang X, Lyu H et al (2019) Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials. Osteoporos Int. https://doi.org/10.1007/s00198-019-05101-8

    Article  PubMed  Google Scholar 

  25. Staples MP, Kallmes DF, Comstock BA et al (2011) Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis. BMJ 342:d3952

    Article  Google Scholar 

  26. Ong KL, Beall DP, Frohberg M, Lau E, Hirsch JA (2018) Were VCF patients at higher risk of mortality following the 2009 publication of vertebroplasty “sham” trials? Osteoporos Int 29:375–383

    Article  CAS  Google Scholar 

Download references

Funding

No funds were received in support of this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terrence Diamond.

Ethics declarations

Conflict of interest

All authors declare that there is no conflict of interest.

Ethical approval

The trial was approved by the Human Research Ethics Committees of Bellberry Limited (2011-08-414) and North Sydney Local Health District (HREC/11/HAWKE/228). The Human Research Committee at each participating centre approved the study, and all patients provided written informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 155 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diamond, T., Clark, W., Bird, P. et al. Early vertebroplasty within 3 weeks of fracture for acute painful vertebral osteoporotic fractures: subgroup analysis of the VAPOUR trial and review of the literature. Eur Spine J 29, 1606–1613 (2020). https://doi.org/10.1007/s00586-020-06362-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-020-06362-2

Keywords

Navigation